Development of a highly selective c-Src kinase inhibitor

ACS Chem Biol. 2012 Aug 17;7(8):1393-8. doi: 10.1021/cb300172e. Epub 2012 Jun 4.

Abstract

Generating highly selective probes to interrogate protein kinase function in biological studies remains a challenge, and new strategies are required. Herein, we describe the development of the first highly selective and cell-permeable inhibitor of c-Src, a key signaling kinase in cancer. Our strategy involves extension of traditional inhibitor design by appending functionality proposed to interact with the phosphate-binding loop of c-Src. Using our selective inhibitor, we demonstrate that selective inhibition is significantly more efficacious than pan-kinase inhibition in slowing the growth of cancer cells. We also show that inhibition of c-Abl kinase, an off-target of most c-Src inhibitors, promotes oncogenic cell growth.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / chemistry
  • Animals
  • Antineoplastic Agents / pharmacology
  • CSK Tyrosine-Protein Kinase
  • Cell Line, Tumor
  • Cell Proliferation
  • Chemistry, Pharmaceutical / methods
  • Drug Design
  • Drug Screening Assays, Antitumor / methods
  • Fibroblasts / cytology
  • Humans
  • Kinetics
  • Mice
  • Models, Chemical
  • Neoplasms / drug therapy
  • Neoplasms / metabolism
  • Phosphates / chemistry
  • Phosphorylation
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Protein-Tyrosine Kinases / chemistry
  • Signal Transduction
  • src-Family Kinases

Substances

  • Antineoplastic Agents
  • Phosphates
  • Protein Kinase Inhibitors
  • Adenosine Triphosphate
  • Protein-Tyrosine Kinases
  • CSK Tyrosine-Protein Kinase
  • src-Family Kinases
  • CSK protein, human